Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 variants of concern, variants of interest and lineage A.27 are on the rise in Côte d’Ivoire

Etilé Augustin Anoh, Grit Schubert, Oby Wayoro, Monemo Pacôme, Essia Belarbi, Andreas Sachse, Sébastien Calvignac-Spencer, Fabian Leendertz, Bamourou Diané, Chantal Akoua-Koffi
doi: https://doi.org/10.1101/2021.05.06.21256282
Etilé Augustin Anoh
1Centre Hospitalier Universitaire Bouaké, Côte d’Ivoire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anohethyl@yahoo.fr schubertg@rki.de CalvignacS@rki.de cakoua26@gmail.com
Grit Schubert
2Robert Koch-Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anohethyl@yahoo.fr schubertg@rki.de CalvignacS@rki.de cakoua26@gmail.com
Oby Wayoro
1Centre Hospitalier Universitaire Bouaké, Côte d’Ivoire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monemo Pacôme
1Centre Hospitalier Universitaire Bouaké, Côte d’Ivoire
3Université Alassane Ouattara de Bouaké, Côte d’Ivoire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Essia Belarbi
2Robert Koch-Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Sachse
2Robert Koch-Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sébastien Calvignac-Spencer
2Robert Koch-Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anohethyl@yahoo.fr schubertg@rki.de CalvignacS@rki.de cakoua26@gmail.com
Fabian Leendertz
2Robert Koch-Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bamourou Diané
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Akoua-Koffi
1Centre Hospitalier Universitaire Bouaké, Côte d’Ivoire
3Université Alassane Ouattara de Bouaké, Côte d’Ivoire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anohethyl@yahoo.fr schubertg@rki.de CalvignacS@rki.de cakoua26@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

SARS-CoV-2 variants of concern (VOC) and variants of interest (VOI) are heavily altering the COVID-19 pandemic’s course due to their increased transmissibility, virulence and immune escape abilities. Data on their spread in western sub-Saharan Africa is however still scarce. We therefore sequenced viral genomes from SARS-CoV-2 cases identified in central and northern Côte d’Ivoire between May 2020 and March 2021. We report the introduction of VOC B.1.1.7 as early as mid-January 2021, followed by detection of a single case of VOC B.1.351, as well as VOI B.1.525. Since early 2021 VOC/VOI are gradually dominating the SARS-CoV-2 virus pool in Côte d’Ivoire, as seen in other regions of the world. Intriguingly, we also find that another lineage, A.27, has also been on the rise over the same period. In sum, this study highlights again the extremely rapid local diffusion of VOC, VOI and possibly A.27, and the importance of further reinforcing capacities for genomic surveillance on the African continent.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study is funded by two grants from the German Federal Ministry of Education and Research (BMBF; grant number 01KA1606; grant number 01KI2047). The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study adheres to the tenets of the Declaration of Helsinki and national ethical and legislation standards. The CHU Bouaké laboratory is part of the national surveillance programme for SARS-CoV-2 diagnosis in Côte d'Ivoire. Approval by institutional ethics committees for conducting the ANDEMIA surveillance study was given by the Comité National d'Ethique des Sciences de la Vie et de la Santé de Côte d'Ivoire (ethics permit number 105/MSHP/CNER-dk), and by the Ethikkommission - Ethikausschuss am Campus Virchow-Klinikum, Charité, Germany (ethics permit number EA2/230/17). The study objectives were explained by trained surveillance officers, and informed written consent for participating in the study was collected from all participants. Written consent was obtained by parents or legal guardians of minors. Personal patient identifiers were not accessible to the authors. Inclusion of SARS-CoV-2 diagnostics into the study was granted by the Comité National d'Ethique des Sciences de la Vie et de la Santé de Côte d'Ivoire (ethics permit number 073-20/MSHP/CNESVS-kp).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

all sequence data are available on GISAID

https://www.gisaid.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 variants of concern, variants of interest and lineage A.27 are on the rise in Côte d’Ivoire
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 variants of concern, variants of interest and lineage A.27 are on the rise in Côte d’Ivoire
Etilé Augustin Anoh, Grit Schubert, Oby Wayoro, Monemo Pacôme, Essia Belarbi, Andreas Sachse, Sébastien Calvignac-Spencer, Fabian Leendertz, Bamourou Diané, Chantal Akoua-Koffi
medRxiv 2021.05.06.21256282; doi: https://doi.org/10.1101/2021.05.06.21256282
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 variants of concern, variants of interest and lineage A.27 are on the rise in Côte d’Ivoire
Etilé Augustin Anoh, Grit Schubert, Oby Wayoro, Monemo Pacôme, Essia Belarbi, Andreas Sachse, Sébastien Calvignac-Spencer, Fabian Leendertz, Bamourou Diané, Chantal Akoua-Koffi
medRxiv 2021.05.06.21256282; doi: https://doi.org/10.1101/2021.05.06.21256282

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8997)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1960)
  • Geriatric Medicine (191)
  • Health Economics (403)
  • Health Informatics (1330)
  • Health Policy (661)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10820)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1834)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1000)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (581)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1907)
  • Public and Global Health (4127)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (550)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)